-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998598 | Anti-CTLA-8 / IL-17a Antibody (SY18-VHH-11), Anti-CTLA-8 / IL-17a Antibody (SY18-VHH-11), |
|||
| A998599 | Anti-CTLA-8 / IL-17a Reference Antibody (CAT-2200), Anti-CTLA-8 / IL-17a Reference Antibody (CAT-2200), |
|||
| A998600 | Anti-CTLA-8 / IL-17a Reference Antibody (ixekizumab), Anti-CTLA-8 / IL-17a Reference Antibody (ixekizumab), |
|||
| A998601 | Anti-CTLA-8 / IL-17a Reference Antibody (netakimab), Anti-CTLA-8 / IL-17a Reference Antibody (netakimab), |
|||
| A998602 | Anti-CTLA-8 / IL-17a Reference Antibody (perakizumab), Anti-CTLA-8 / IL-17a Reference Antibody (perakizumab), |
|||
| A998603 | Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab), Anti-CTLA-8 / IL-17a Reference Antibody (secukinumab), |
|||
| A998604 | Anti-CTLA-8 / IL-17a Reference Antibody (UCB patent anti-IL-17), Anti-CTLA-8 / IL-17a Reference Antibody (UCB patent anti-IL-17), |
|||
| A998605 | Anti-CTLA-8 / IL-17a Reference Antibody (vunakizumab), Anti-CTLA-8 / IL-17a Reference Antibody (vunakizumab), |
|||
| A666741 | Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-like Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-like |
|||
| A666726 | Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-scFv Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-scFv |
|||
| A666787 | Anti-CTLA4 & PD-L1 Reference Antibody (Erfonrilimab), Target:CTLA4&PD-L1,Uniprot:P16410&Q9NZQ7,Species:Human,isotype:VHH Anti-CTLA4 & PD-L1 Reference Antibody (Erfonrilimab), Target:CTLA4&PD-L1,Uniprot:P16410&Q9NZQ7,Species:Human,isotype:VHH |
|||
| A998606 | Anti-CTSS / Cathepsin S Reference Antibody (Fsn0503h), Anti-CTSS / Cathepsin S Reference Antibody (Fsn0503h), |
|||
| A998607 | Anti-CX3CL1 / Fractalkine Reference Antibody (quetmolimab), Anti-CX3CL1 / Fractalkine Reference Antibody (quetmolimab), |
|||
| A998608 | Anti-CXADR Reference Antibody (Med. Bio. Labs patent anti-CXADR), Anti-CXADR Reference Antibody (Med. Bio. Labs patent anti-CXADR), |
|||
| A998609 | Anti-CXC-ELR Reference Antibody (Lilly patent anti-Pan-ELR+), Anti-CXC-ELR Reference Antibody (Lilly patent anti-Pan-ELR+), |
|||
| A998610 | Anti-CXCL10 / IP-10 Reference Antibody (eldelumab), Anti-CXCL10 / IP-10 Reference Antibody (eldelumab), |
|||
| A998611 | Anti-CXCL10 / IP-10 Reference Antibody (NI-0801), Anti-CXCL10 / IP-10 Reference Antibody (NI-0801), |
|||
| A998612 | Anti-CXCL12 / SDF1a Reference Antibody (Genentech anti-CXCL12), Anti-CXCL12 / SDF1a Reference Antibody (Genentech anti-CXCL12), |
|||
| A998613 | Anti-CXCL4 / PF4 Reference Antibody (U.Penn. patent anti-PF4), Anti-CXCL4 / PF4 Reference Antibody (U.Penn. patent anti-PF4), |
|||
| A998614 | Anti-CXCL8 / IL-8 Reference Antibody (ABX-IL8), Anti-CXCL8 / IL-8 Reference Antibody (ABX-IL8), |
